← Every applicant
Amta FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| TOPIRAMATENew drugDec 3, 2024CAPSULE, EXTENDED RELEASE, ORAL |
| MESALAMINENew drugJun 6, 2023CAPSULE, EXTENDED RELEASE, ORAL |
| NISOLDIPINENew drugApr 10, 2023TABLET, EXTENDED RELEASE, ORAL |
| DILTIAZEM HYDROCHLORIDENew drugMar 7, 2023TABLET, EXTENDED RELEASE, ORAL |